Skip to main content

Table 1 The expressions of Oct4 and Sox2 and their relationships with clinicopathological characteristics.

From: Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma

Features

No. patients

OCT4

P a

SOX2

P a

  

High

Low

 

High

Low

 

Gender

      

   Female

1

0

1

-

1

0

-

   Male

84

14

70

 

66

18

 

Age (years)b

      

   <60

41

7

34

0.885

35

6

0.154

   ≥60

44

7

37

 

32

12

 

Histological grade

      

   Well

34

5

29

0.572

28

6

0.030

   Moderately

39

8

31

 

33

6

 

   Poorly

12

1

11

 

6

6

 

SCCAc (ng/ml)

      

   ≤ 1

43

8

35

0.348

34

9

0.794

   > 1

21

2

19

 

16

5

 

TSGFd (ng/ml)

      

   ≤ 70

33

4

29

0.298

24

9

0.230

   > 70

22

5

17

 

19

3

 

T Stage

      

   1~2

21

3

18

0.756

16

5

0.734

   3~4

64

11

53

 

51

13

 

Cervical lymph node metastasis

     

   Positive

19

7

12

0.007

16

3

0.514

   Negative

66

7

59

 

51

15

 

TNM Stage

      

   I~II

7

1

6

0.871

4

3

0.143

   III~IV

78

13

65

 

63

15

 

Treatment Typee

       

   L + N

7

5

2

-

5

2

-

   L + N+ R

4

1

3

 

3

1

 

   L + N + C

4

1

3

 

3

1

 

   L + N + R + C

6

0

6

 

2

4

 

   N + R

2

0

2

 

1

1

 

   N + R + C

6

2

4

 

4

2

 

   R

3

1

2

 

2

1

 

   R + C

21

2

19

 

20

1

 

   C

20

1

19

 

17

3

 

No treatment or tracheotomy

12

1

11

 

10

2

 
  1. a Chi-square test
  2. b Patients were divided according to the median values of age.
  3. c SCCA, Squamous Cell Carcinoma Antigen
  4. d TSGF, Tumor Supplied Group of Factor
  5. e L = Laryngectomy, N = Neck dissection, R = Radiotherapy, C = Chemotherapy